Bobulsky Susan

Bobulsky Susan is listed in filings as Chief Commercial Officer at Adaptive Biotechnologies Corporation. This profile follows SEC Form 4 activity through Jun 15, 2026, including sale activity. Recent filings connect the profile to Adaptive Biotechnologies Corporation (ADPT). The current snapshot covers public activity from Mar 6, 2025 to Jun 15, 2026. Reported amounts are shown as $95.0K to $181.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.